Incidence of Venous Thromboembolism: The 3 rd Korean Nationwide Study
10.3346/jkms.2022.37.e130
- Author:
Hun-Gyu HWANG
1
;
Ju Hyun LEE
;
Sang-A KIM
;
Yang-Ki KIM
;
Ho-Young YHIM
;
Junshik HONG
;
Soo-Mee BANG
Author Information
1. Respiratory Division, Department of Internal Medicine, Soonchunhyang University, School of Medicine, Gumi Hospital, Korea
- Publication Type:Original Article
- From:Journal of Korean Medical Science
2022;37(17):e130-
- CountryRepublic of Korea
- Language:English
-
Abstract:
Background:The incidence of venous thromboembolism (VTE) has gradually increased in the Korean population. This study aimed to evaluate the annual age- and sex-adjusted incidence rates (ASR) of VTE and anticoagulation trends between 2014 and 2018.
Methods:Using the Korean Health Insurance Review and Assessment Service database, we retrospectively identified VTE patients between 2014 and 2018 using both diagnostic and medication anticoagulant codes assigned within 6 months of the initial index event. Anticoagulant patterns were classified as follows: direct oral anticoagulants (DOAC), panticoagulants, warfarin, and mixed anticoagulation regimens.
Results:We identified 95,205 patients with VTE (female, 56.8%). The ASR for VTE per 100,000 person-years increased from 32.8 in 2014 to 53.7 cases in 2018 (relative risk of 1.63; 95% confidence interval, 1.6–1.67). The VTE incidence rates were 25 times higher in the ≥ 80 group than in the 30s group. VTE occurred 1.29 times more often in women than in men. The proportion of DOAC prescriptions increased from 40.5% to 72.8%, whereas warfarin prescriptions decreased from 27% to 5.6% in 2014 and 2018.
Conclusion:In Korea, the ASRs of VTE continued to increase since 2014, but the rate of increase slowed in 2018. The VTE occurred more often in the elderly and in women. Five years after the introduction of DOACs in 2013, they accounted for 73% of all anticoagulants used to treat VTE.
